Jump Financial’s Harvard Bioscience HBIO Stock Holding History

Jump Financial’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,119	Closed	-$336K	–	2002
2023 Q2	$336K	Buy	+6,119	New	+$336K	0.01%	1248
2022 Q3	–	Sell	-3,940	Closed	-$142K	–	1732
2022 Q2	$142K	Buy	+3,940	New	+$178K	0.01%	1381
2021 Q3	–	Sell	-2,130	Closed	-$177K	–	1249
2021 Q2	$177K	Buy	2,130 +640	+43%	+$45.3K	0.02%	898
2021 Q1	$81K	Buy	+1,490	New	+$72.5K	0.01%	855

Other funds holding HBIO

272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Jump Financial's HBIO Position: Q3 2023 in Review

Jump Financial sold out of Harvard Bioscience (HBIO) in Q3 2023, closing a stake of 6,119 shares — an estimated $336K sold.

Jump Financial first reported a position in HBIO in Q1 2021 and held it in 4 quarters. The position peaked at $336K in Q2 2023. 94 funds tracked by Wall St. Rank hold HBIO as of Q3 2023.

Jump Financial reported no remaining Harvard Bioscience position as of Q3 2023 after selling out during the quarter.
Jump Financial sold 6,119 Harvard Bioscience shares in Q3 2023, an estimated $336K.
Jump Financial first reported a position in Harvard Bioscience in Q1 2021 and held it in 4 quarters.
Jump Financial's Harvard Bioscience position peaked at $336K in Q2 2023.
94 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2023.

Based on Jump Financial's 13F filing for Q3 2023, filed 7 Nov 2023.